PHILADELPHIA, July 13 /PRNewswire-FirstCall/ -- ERT , a leading provider of centralized ECG, ePRO, eClinical technology, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will release its results for the 2009 second quarter on Thursday, July 30, 2009 after the market closes. After the release, the Company will host a conference call at 5:00 PM EDT that day.
For the conference call, interested participants should dial 1-800-638-4930 when calling within the United States or 1-617-614-3944 when calling internationally. Please use pass code 71733855. There will be a playback available as well. To listen to the playback, please call 1- 888-286-8010 when calling within the United States or 1-617-801-6888 when calling internationally. Please use pass code 26054685 for the replay.
This call is being webcast by Thomson Financial and can be accessed at ERT's website at http://www.ert.com/. The webcast may also be accessed at Thomson's Institutional Investor website at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=119164&eventID =2319674. The webcast can be accessed for up to one year on either site.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including but not limited to 2009 financial guidance, involve a number of risks and uncertainties such as the company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope, and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
ERT
CONTACT: Keith Schneck, CFO of ERT, +1-215-972-0420, kschneck@ert.com
Web Site: http://www.ert.com/
